跳至主要内容
临床试验/NCT07123896
NCT07123896尚未招募不适用

Arrhythmia Cohort Study

Beijing Anzhen Hospital1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2025年8月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10,000
试验地点
1
主要终点
Arrhythmia recurrence

研究概览

简要总结

The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients hospitalized for any type of arrhythmia

排除标准

  • Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.

研究组 & 干预措施

Treatment

干预措施: Normal treatment with catheter ablation or medicine (Device)

Treatment

干预措施: Drug Treatment (Drug)

结局指标

主要结局

Arrhythmia recurrence

时间窗: 1 year

Recurrence of the arrhythmia after treatment

All-cause death

时间窗: 1 year

Death due to any reason

次要结局

  • Arrhythmia recurrence(5 year)
  • All-cause death(5 year)
  • Cardiovascular death(5 year)
  • Heart failure(5 year)
  • Cardiovascular hospitalization(5 year)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验